RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of BNTC
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Green day on Thursday for Benitec Biopharma Limited
(Updated on Mar 28, 2024)

Buy or Hold candidate since Mar 04, 2024 Gain 10.76% PDF

The Benitec Biopharma Limited stock price gained 2.34% on the last trading day (Thursday, 28th Mar 2024), rising from $5.13 to $5.25. During the last trading day the stock fluctuated 4.36% from a day low at $5.05 to a day high of $5.27. The price has risen in 5 of the last 10 days and is up by 1.55% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 17 thousand more shares were traded than the day before. In total, 21 thousand shares were bought and sold for approximately $110.61 thousand.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 75.67% during the next 3 months and, with a 90% probability hold a price between $7.33 and $11.40 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

BNTC Signals & Forecast

The Benitec Biopharma Limited stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $5.10 and $4.40. A breakdown below any of these levels will issue sell signals. Benitec Biopharma Limited has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Friday, March 01, 2024, and so far it has fallen -6.58%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Benitec Biopharma Limited stock

On the downside, the stock finds support just below today's level from accumulated volume at $4.74 and $4.50. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Benitec Biopharma Limited finds support just below today's level at $4.74. If this is broken, then the next support from accumulated volume will be at $4.50 and $4.23.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.220 between high and low, or 4.36%. For the last week, the stock has had daily average volatility of 5.75%.

Our recommended stop-loss: $5.05 (-3.89%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 19 days ago.)

Trading Expectations (BNTC) For The Upcoming Trading Day Of Monday 1st

For the upcoming trading day on Monday, 1st we expect Benitec Biopharma Limited to open at $5.19, and during the day (based on 14 day Average True Range), to move between $4.92 and $5.58, which gives a possible trading interval of +/-$0.326 (+/-6.20%) up or down from last closing price. If Benitec Biopharma Limited takes out the full calculated possible swing range there will be an estimated 12.41% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $5.33 (1.52%) than the support at $4.74 (9.71%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Benitec Biopharma Limited stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Benitec Biopharma Limited stock to perform well in the short-term.

Current score: 3.728 Buy Candidate Unchanged

Predicted Opening Price for Benitec Biopharma Limited of Monday, April 1, 2024

Fair opening price April 1, 2024 Current price
$5.19 ( 1.14%) $5.25

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for BNTC

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 5.41 3.05 %
R2 5.33 1.45 %
R1 5.27 0.458 %
Current price: 5.25
Support S1 5.11 -2.74 %
S2 5.05 -3.73 %
S3 4.97 -5.33 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 5.62 7.05 %
R2 5.35 1.90 %
R1 5.33 1.52 %
Current price 5.25
Support S1 4.74 -9.71%
S2 4.50 -14.29%
S3 4.23 -19.43%

BNTC Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 May 25, 2018 Jun 01, 2018 Jun 08, 2018 $0.0450 0.0071%

FAQ

What is the symbol for Benitec Biopharma Limited Stock and on which exchange is it traded?
The symbol for Benitec Biopharma Limited is BNTC and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Benitec Biopharma Limited Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Benitec Biopharma Limited stock to perform well in the short-term.

How to buy Benitec Biopharma Limited Stock?
Benitec Biopharma Limited Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Benitec Biopharma Limited Stock.

What's the current price of Benitec Biopharma Limited Stock?
As of the end of day on the 2024-03-28, the price of an Benitec Biopharma Limited (BNTC) share was $5.25.

What is the 52-week high and low for Benitec Biopharma Limited Stock?
The 52-week high for Benitec Biopharma Limited Stock is $5.94 and the 52-week low is $0.161.

What is the market capitalization of Benitec Biopharma Limited Stock?
As of the 2024-03-28, the market capitalization of Benitec Biopharma Limited is 13.61M.

When is the next earnings date for Benitec Biopharma Limited?
The upcoming earnings date for Benitec Biopharma Limited is May 13, 2024.
Click to get the best stock tips daily for free!

About Benitec Biopharma Limited

Benitec Biopharma Limited Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy; and BB-103 for the treatment of chronic hepatitis B virus infection. The company w... BNTC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT